eGenesis, Inc.

300 Technology Square
02139 Cambridge
USA

About eGenesis

eGenesis is a gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues and cells to address the global organ crisis.

Product portfolio of eGenesis

Product portfolio

Show all

Advanced Virus Quantification for Real-Time Process Control

Maximum binding capacity in ion exchange chromatography

Advanced CHO Cell Line Development Technology for In-House Implementation

News about eGenesis

11-Nov-2019 | business & finance

Bayer invests USD 50 Million in eGenesis Series B financing round

Investment to support development of human-compatible xeno organs to address the global organ shortage crisis

Read news

Show more news about eGenesis

First CO₂ Incubator Shaker with Integrated 180°C Sterilization

Screening and Purification for Large Biomolecules in Multi-Well Plate Design

High-Performance Sterilizing-Grade Filtration for Solvents and Oily Formulations

Here you will find eGenesis, Inc.

Last viewed contents

eGenesis, Inc.

About eGenesis

Product portfolio of eGenesis

Product portfolio

News about eGenesis

Bayer invests USD 50 Million in eGenesis Series B financing round

Here you will find eGenesis, Inc.

Last viewed contents

Sluggish cell division during development may help explain genital defects

Tecan Austria GmbH - Grödig, Austria

Engineers design programmable RNA vaccines

Mecana Umwelttechnik AG - Reichenburg, Switzerland

ELDICO Scientific AG - Villigen, Switzerland

eGenesis, Inc.